Rallybio Corp Stock Probability of Future Stock Price Finishing Over 1.04
| RLYB Stock | USD 1.17 0.07 6.36% |
Rallybio |
Rallybio Corp Target Price Odds to finish over 1.04
The tendency of Rallybio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above $ 1.04 in 90 days |
| 1.17 | 90 days | 1.04 | about 76.25 |
Based on a normal probability distribution, the odds of Rallybio Corp to stay above $ 1.04 in 90 days from now is about 76.25 (This Rallybio Corp probability density function shows the probability of Rallybio Stock to fall within a particular range of prices over 90 days) . Probability of Rallybio Corp price to stay between $ 1.04 and its current price of $1.17 at the end of the 90-day period is about 70.84 .
Given the investment horizon of 90 days Rallybio Corp has a beta of 0.5 indicating as returns on the market go up, Rallybio Corp average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Rallybio Corp will be expected to be much smaller as well. Additionally Rallybio Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Rallybio Corp Price Density |
| Price |
Predictive Modules for Rallybio Corp
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Rallybio Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Rallybio Corp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Rallybio Corp Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Rallybio Corp is not an exception. The market had few large corrections towards the Rallybio Corp's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Rallybio Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Rallybio Corp within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.22 | |
β | Beta against Dow Jones | 0.50 | |
σ | Overall volatility | 0.06 | |
Ir | Information ratio | -0.11 |
Rallybio Corp Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Rallybio Corp for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Rallybio Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Rallybio Corp may become a speculative penny stock | |
| Net Loss for the year was (74.56 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Rallybio Corp currently holds about 147.37 M in cash with (60.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Rallybio Corp has a poor financial position based on the latest SEC disclosures | |
| Over 76.0% of the company shares are owned by institutional investors | |
| Latest headline from businesswire.com: Rallybio Announces Publication of Target-Mediated Drug Disposition Modeling and Simulations Informing the RLYB212 Dosing Regimen in Pregnant Women |
Rallybio Corp Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Rallybio Stock often depends not only on the future outlook of the current and potential Rallybio Corp's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rallybio Corp's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 40.4 M | |
| Cash And Short Term Investments | 109.9 M |
Rallybio Corp Technical Analysis
Rallybio Corp's future price can be derived by breaking down and analyzing its technical indicators over time. Rallybio Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Rallybio Corp. In general, you should focus on analyzing Rallybio Stock price patterns and their correlations with different microeconomic environments and drivers.
Rallybio Corp Predictive Forecast Models
Rallybio Corp's time-series forecasting models is one of many Rallybio Corp's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Rallybio Corp's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Rallybio Corp
Checking the ongoing alerts about Rallybio Corp for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Rallybio Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Rallybio Corp may become a speculative penny stock | |
| Net Loss for the year was (74.56 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Rallybio Corp currently holds about 147.37 M in cash with (60.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Rallybio Corp has a poor financial position based on the latest SEC disclosures | |
| Over 76.0% of the company shares are owned by institutional investors | |
| Latest headline from businesswire.com: Rallybio Announces Publication of Target-Mediated Drug Disposition Modeling and Simulations Informing the RLYB212 Dosing Regimen in Pregnant Women |
Check out Rallybio Corp Backtesting, Rallybio Corp Valuation, Rallybio Corp Correlation, Rallybio Corp Hype Analysis, Rallybio Corp Volatility, Rallybio Corp History as well as Rallybio Corp Performance. For information on how to trade Rallybio Stock refer to our How to Trade Rallybio Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rallybio Corp. If investors know Rallybio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rallybio Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.57) | Revenue Per Share 0.014 | Return On Assets (0.39) | Return On Equity (0.67) |
The market value of Rallybio Corp is measured differently than its book value, which is the value of Rallybio that is recorded on the company's balance sheet. Investors also form their own opinion of Rallybio Corp's value that differs from its market value or its book value, called intrinsic value, which is Rallybio Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rallybio Corp's market value can be influenced by many factors that don't directly affect Rallybio Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rallybio Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rallybio Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rallybio Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.